HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiro Shimoji Selected Research

Swine Erysipelas

1/2020Erysipelothrix Spp.: Past, Present, and Future Directions in Vaccine Research.
12/2019Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas.
12/2019A putative transcription regulator involved in the virulence attenuation of an acriflavine-resistant vaccine strain of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas.
5/2019Disassociation of Spa type and serovar of an Erysipelothrix rhusiopathiae serovar 6 strain isolated from a diseased pig.
8/2014Phosphorylcholine and SpaA, a choline-binding protein, are involved in the adherence of Erysipelothrix rhusiopathiae to porcine endothelial cells, but this adherence is not mediated by the PAF receptor.
11/2012Capsular polysaccharide of Erysipelothrix rhusiopathiae, the causative agent of swine erysipelas, and its modification with phosphorylcholine.
7/2009Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiro Shimoji Research Topics

Disease

7Swine Erysipelas
01/2020 - 07/2009
6Infections
01/2020 - 02/2002
2Salmonella Infections (Salmonellosis)
01/2020 - 01/2015
2Erysipelas
01/2020 - 01/2002
2Mycoplasmal Pneumonia of Swine (Swine Mycoplasmal Pneumonia)
07/2009 - 01/2003
1Chronic Disease (Chronic Diseases)
04/2017
1Vascular Diseases (Vascular Disease)
08/2014
1Endotoxemia
08/2002

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
01/2020 - 01/2003
3AntigensIBA
01/2020 - 10/2008
3Interleukin-18 (Interleukin 18)IBA
10/2008 - 08/2002
2AntibodiesIBA
01/2020 - 01/2002
2Immunoglobulin G (IgG)IBA
01/2020 - 01/2002
2Monoclonal AntibodiesIBA
01/2016 - 01/2015
2Phosphorylcholine (Phosphocholine)IBA
08/2014 - 11/2012
1AcriflavineIBA
12/2019
1Proteins (Proteins, Gene)FDA Link
05/2019
1spiropentaneacetic acid (SPAA)IBA
05/2019
1ImmunosorbentsIBA
01/2015
1EnzymesIBA
01/2015
11,3,4,5,6-pentachlorocyclohexene-1-oxideIBA
08/2014
1Attenuated VaccinesIBA
06/2013
1Polysaccharides (Glycans)IBA
11/2012
1CytokinesIBA
10/2008
1Concanavalin AIBA
10/2008
1Interleukin-8 (Interleukin 8)IBA
10/2008
1Interleukin-10 (Interleukin 10)IBA
10/2008
1Recombinant ProteinsIBA
01/2003
1LipopolysaccharidesIBA
08/2002
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
02/2002

Therapy/Procedure

1Subcutaneous Injections
07/2009